An Analytical Study on Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

ABSTRACT: The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a flagship initiative by the Government of India aimed at making quality generic medicines accessible and affordable to the general public. Launched in 2008, and gaining momentum post-2015 under the direct impetus of the Hon’ble Prime Minister, PMBJP has made significant strides in improving healthcare accessibility. As of 31st March 2024, over 11,261 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been established across the nation. This paper analyzes the scheme's growth trajectory, its impact in terms of cost savings to the public, and its effectiveness as a public health intervention. The study employs quantitative analysis of data across five years to assess the expansion of Kendras, product availability, and sales trends.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-30
DOI
https://doi.org/10.5281/zenodo.15788718
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Analytical Study on Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Economics and Policy
article

An Analytical Study on Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

article en

Abstract

ABSTRACT: The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a flagship initiative by the Government of India aimed at making quality generic medicines accessible and affordable to the general public. Launched in 2008, and gaining momentum post-2015 under the direct impetus of the Hon’ble Prime Minister, PMBJP has made significant strides in improving healthcare accessibility. As of 31st March 2024, over 11,261 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been established across the nation. This paper analyzes the scheme's growth trajectory, its impact in terms of cost savings to the public, and its effectiveness as a public health intervention. The study employs quantitative analysis of data across five years to assess the expansion of Kendras, product availability, and sales trends.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 41%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.